Buy Stocks Easy | About Us
January 19, 2022
Buy Stocks Easy | Online Stocks

TRVN


Buy Trevena, Inc. Stock (symbol: TRVN) Easy Online

Company Name: Trevena, Inc.

Symbol: TRVN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

TRVN Current Share Price

Today's TRVN ( Trevena, Inc. ) opening price: $0.7351

Yesterday's TRVN ( Trevena, Inc. ) closing price: $0.7355

Trevena, Inc. Stock ( symbol: TRVN ) Price Chart since IPO (2014):

12 Months Trevena, Inc. Stock ( symbol: TRVN ) Price Chart

Popular Questions about Trevena, Inc. Public Stock ( TRVN )

A: Trevena, Inc. stock symbol (also called stock or share ticker) is TRVN

A: Trevena, Inc. IPO (Initial Public Offering) took place on 2014

A: Trevena, Inc.'s stock (TRVN symbol) price at ther IPO (initial Public Offering) was $0.7351

Q: Is TRVN stock worth buying at the moment?

A: The TRVN stock performance since 2019 are rather disappointing. If you had bought 1 share of Trevena, Inc. stock (symbol: TRVN) at the beginning of 2019, at the opening share price of $1.0700, you would be left with exactly $0.7351 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Trevena, Inc. Stock Easy Online

Trevena, Inc. Stock Ticker Price Chart since IPO:





Trevena, Inc. Stock Price Yesterday



 


Trevena, Inc. Stock Price – Last Week




 


Trevena, Inc. Stock Price – Last Month




 


Trevena, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/23/1963999/0/en/Trevena-Announces-Initiation-of-Proof-of-Concept-Study-for-TRV734-for-Potential-Treatment-of-Opioid-Use-Disorder.html
                            

                                
Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder

                                
                                
CHESTERBROOK, Pa., Dec.  23, 2019  (GLOBE NEWSWIRE) -- Trevena, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/12/1959770/0/en/Trevena-Presents-Phase-1-Data-on-TRV250-for-Acute-Migraine-at-American-College-of-Neuropsychopharmacology-2019-Annual-Meeting.html
                            

                                
Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting

                                
                                
Safety, tolerability, and PK profile support potential utility as a...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/20/1950009/0/en/Trevena-Announces-Publication-of-Results-from-Special-Population-Studies-for-Oliceridine.html
                            

                                
Trevena Announces Publication of Results from Special Population Studies for Oliceridine

                                
                                
No dose adjustments required for patients with renal impairment or ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/20/1949999/0/en/Trevena-Announces-Publication-of-Results-from-Phase-3-Real-World-Safety-Study-for-Oliceridine-in-The-Journal-of-Pain-Research.html
                            

                                
Trevena Announces Publication of Results from Phase 3 “Real World” Safety Study for Oliceridine in The Journal of Pain Research

                                
                                
Safety and tolerability demonstrated in diverse patient populations...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/18/1949014/0/en/Trevena-to-Present-at-the-Stifel-2019-Healthcare-Conference.html
                            

                                
Trevena to Present at the Stifel 2019 Healthcare Conference

                                
                                
CHESTERBROOK, Pa., Nov.  18, 2019  (GLOBE NEWSWIRE) -- Trevena, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/21/1932690/0/en/Trevena-Announces-Presentations-at-the-American-Society-of-Anesthesiologists-2019-Annual-Meeting.html
                            

                                
Trevena Announces Presentations at the American Society of Anesthesiologists 2019 Annual Meeting

                                
                                
CHESTERBROOK, Pa., Oct.  21, 2019  (GLOBE NEWSWIRE) -- Trevena, Inc...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/27/1921758/0/en/Trevena-to-Present-at-the-2019-Cantor-Global-Healthcare-Conference.html
                            

                                
Trevena to Present at the 2019 Cantor Global Healthcare Conference

                                
                                
CHESTERBROOK, Pa., Sept.  27, 2019  (GLOBE NEWSWIRE) -- Trevena, In...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/501002/trevena-sees-hammer-chart-pattern-time-to-buy
                            

                                
Trevena Sees Hammer Chart Pattern: Time to Buy?

                                
                                
Trevena has been struggling lately, but the selling pressure may be...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1909840/0/en/Trevena-to-Participate-in-Upcoming-Conferences-in-September-2019.html
                            

                                
Trevena to Participate in Upcoming Conferences in September 2019

                                
                                
CHESTERBROOK, Pa., Sept.  03, 2019  (GLOBE NEWSWIRE) -- Trevena, In...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.